Attachments
PDF
Share price
+3.67%
Share price
+3.67%
Open
0.71
High
0.73
Low
0.65
Close
0.73
Share price change during the day of this press release
(SEK).
Calendar
| Est. time* | ||
| 2025-10-23 | 08:10 | Quarterly Report 2025-Q3 |
| 2025-08-21 | 08:10 | Quarterly Report 2025-Q2 |
| 2025-05-09 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2025-04-24 | - | Quarterly Report 2025-Q1 |
| 2025-02-20 | - | Year-end Report 2024 |
| 2024-10-24 | - | Quarterly Report 2024-Q3 |
| 2024-08-22 | - | Quarterly Report 2024-Q2 |
| 2024-07-09 | - | Extra General Meeting 2024 |
| 2024-04-25 | - | Quarterly Report 2024-Q1 |
| 2024-04-19 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2024-04-18 | - | Annual General meeting |
| 2024-02-22 | - | Year-end Report 2023 |
| 2023-10-26 | - | Quarterly Report 2023-Q3 |
| 2023-08-24 | - | Quarterly Report 2023-Q2 |
| 2023-06-29 | - | Annual General meeting |
| 2023-05-12 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2023-04-20 | - | Quarterly Report 2023-Q1 |
| 2023-02-23 | - | Year-end Report 2022 |
| 2022-10-27 | - | Quarterly Report 2022-Q3 |
| 2022-08-11 | - | Quarterly Report 2022-Q2 |
| 2022-05-25 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2022-05-24 | - | Annual General meeting |
| 2022-04-21 | - | Quarterly Report 2022-Q1 |
| 2022-02-17 | - | Year-end Report 2021 |
| 2021-10-28 | - | Quarterly Report 2021-Q3 |
| 2021-08-12 | - | Quarterly Report 2021-Q2 |
| 2021-05-26 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2021-05-25 | - | Annual General meeting |
| 2021-04-22 | - | Quarterly Report 2021-Q1 |
| 2021-02-17 | - | Year-end Report 2020 |
| 2020-10-30 | - | Quarterly Report 2020-Q3 |
| 2020-08-14 | - | Quarterly Report 2020-Q2 |
| 2020-05-26 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2020-05-25 | - | Annual General meeting |
| 2020-04-23 | - | Quarterly Report 2020-Q1 |
| 2020-02-17 | - | Year-end Report 2019 |
| 2019-10-30 | - | Quarterly Report 2019-Q3 |
| 2019-08-15 | - | Quarterly Report 2019-Q2 |
| 2019-05-22 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2019-05-21 | - | Annual General meeting |
| 2019-04-24 | - | Quarterly Report 2019-Q1 |
| 2019-02-14 | - | Year-end Report 2018 |
| 2018-11-01 | - | Quarterly Report 2018-Q3 |
| 2018-08-16 | - | Quarterly Report 2018-Q2 |
| 2018-05-23 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2018-05-22 | - | Annual General meeting |
| 2018-04-26 | - | Quarterly Report 2018-Q1 |
| 2018-02-08 | - | Year-end Report 2017 |
| 2017-11-02 | - | Quarterly Report 2017-Q3 |
| 2017-08-17 | - | Quarterly Report 2017-Q2 |
| 2017-05-24 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2017-05-23 | - | Annual General meeting |
| 2017-04-27 | - | Quarterly Report 2017-Q1 |
| 2017-02-16 | - | Year-end Report 2016 |
| 2016-11-07 | - | Quarterly Report 2016-Q3 |
| 2016-08-16 | - | Quarterly Report 2016-Q2 |
| 2016-06-04 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2016-05-26 | - | Annual General meeting |
| 2016-04-28 | - | Quarterly Report 2016-Q1 |
| 2016-02-18 | - | Year-end Report 2015 |
| 2015-11-11 | - | Quarterly Report 2015-Q3 |
| 2015-08-14 | - | Quarterly Report 2015-Q2 |
| 2015-06-04 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2015-06-03 | - | Annual General meeting |
| 2015-05-07 | - | Quarterly Report 2015-Q1 |
| 2015-02-26 | - | Year-end Report 2014 |
| 2014-11-13 | - | Quarterly Report 2014-Q3 |
| 2014-08-15 | - | Quarterly Report 2014-Q2 |
| 2014-06-11 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2014-06-10 | - | Annual General meeting |
| 2014-05-09 | - | Quarterly Report 2014-Q1 |
| 2014-02-28 | - | Year-end Report 2013 |
| 2013-11-22 | - | Quarterly Report 2013-Q3 |
| 2013-08-23 | - | Quarterly Report 2013-Q2 |
| 2013-06-26 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2013-06-25 | - | Annual General meeting |
| 2013-05-23 | - | Quarterly Report 2013-Q1 |
| 2013-02-25 | - | Year-end Report 2012 |
| 2012-11-23 | - | Quarterly Report 2012-Q3 |
| 2012-08-24 | - | Quarterly Report 2012-Q2 |
| 2012-06-28 | - | Annual General meeting |
| 2012-06-06 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2012-05-24 | - | Quarterly Report 2012-Q1 |
| 2012-02-24 | - | Year-end Report 2011 |
| 2011-12-09 | - | Extra General Meeting 2011 |
| 2011-11-25 | - | Quarterly Report 2011-Q3 |
| 2011-08-26 | - | Quarterly Report 2011-Q2 |
| 2011-06-29 | - | Annual General meeting |
| 2011-06-20 | - | Ex-date Ordinary Dividend LEVBIO 0.00 SEK |
| 2011-05-31 | - | Quarterly Report 2011-Q1 |
| 2011-02-28 | - | Year-end Report 2010 |
| 2010-11-25 | - | Quarterly Report 2010-Q3 |
| 2010-06-18 | - | Annual General meeting |
| 2010-05-20 | - | Quarterly Report 2010-Q1 |
| 2009-11-19 | - | Quarterly Report 2009-Q3 |
Description
| Country | Sweden |
|---|---|
| List | Nordic SME Sweden |
| Sector | Health care |
| Industry | Medical technology |
2023-02-22 08:30:00
AlphaHelix dotterbolag CyberGene AB har ingått ett icke-exklusivt avtal med Thang Long Science Technique., JSC, för distribution av CyberGenes CE-IVD godkända produkter i Vietnam. Ett estimerat antal om 1,5 miljoner födslar årligen i Vietnam gör det till en av de större marknaderna i Asien där CyberGene ser ett stort värde i att kunna erbjuda snabb och kostnadseffektiv diagnostik.
CyberGene har sen tidigare ett icke-exklusivt avtal på plats för distribution i Vietnam men ser detta som ett steg i att stärka möjligheterna till att etablera sig i landet.
Kontaktperson på CyberGene AB:
Joakim Grånemo
070 819 33 90
joakim@cybergene.se
Kontaktperson på AlphaHelix Molecular Diagnostics AB (Publ.):
VD Mikael Havsjö
070 788 12 08
Mikael.havsjo@alphahelix.com
AlphaHelix Molecular Diagnostics AB (publ) utvecklar inom dotterbolaget AlphaHelix Technologies AB instrument för snabba DNA-analyser. Dotterbolaget Techtum Lab AB är en etablerad distributör av laboratorieinstrument och förbrukningsvaror sedan 1975. Dotterbolaget Cybergene är pionjärer inom genetisk fosterdiagnostik sedan 2004.